Shanghai Fosun Pharmaceutical (Group)'s Blood Health Medication Gets NMPA's Nod

MT Newswires Live

2024/12/03

Shanghai Fosun Pharmaceutical (Group) (HKG:2196) unit Hebei Wanbang Folon Pharmaceutical's Tao Hong Si Wu Granules drug registration application was accepted by China's National Medical Products Administration (NMPA), according to a Tuesday filing with the Hong Kong bourse.

The New Drug is a traditional Chinese medicine for nourishing blood, activating blood circulation, and removing blood stasis. It is intended to be used for blood deficiency and blood stasis syndrome, among other issues, the filing added.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2488990787"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2488990787\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2488990787?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-03 19:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2488990787","market":"fut","top_or_hot":-1,"title":"Shanghai Fosun Pharmaceutical (Group)'s Blood Health Medication Gets NMPA's Nod","media":"MT Newswires Live","content":"<html><body><p> Shanghai Fosun Pharmaceutical (Group) (HKG:2196) unit Hebei Wanbang Folon Pharmaceutical's Tao Hong Si Wu Granules drug registration application was accepted by China's National Medical Products Administration (NMPA), according to a Tuesday filing with the Hong Kong bourse.</p><p>The New Drug is a traditional Chinese medicine for nourishing blood, activating blood circulation, and removing blood stasis. It is intended to be used for blood deficiency and blood stasis syndrome, among other issues, the filing added.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Fosun Pharmaceutical (Group)'s Blood Health Medication Gets NMPA's Nod</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Fosun Pharmaceutical (Group)'s Blood Health Medication Gets NMPA's Nod\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-12-03 19:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Shanghai Fosun Pharmaceutical (Group) (HKG:2196) unit Hebei Wanbang Folon Pharmaceutical's Tao Hong Si Wu Granules drug registration application was accepted by China's National Medical Products Administration (NMPA), according to a Tuesday filing with the Hong Kong bourse.</p><p>The New Drug is a traditional Chinese medicine for nourishing blood, activating blood circulation, and removing blood stasis. It is intended to be used for blood deficiency and blood stasis syndrome, among other issues, the filing added.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1230","symbol_name":"工业集团企业","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2488990787","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2488990787","pubTimestamp":1733224128,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shanghai Fosun Pharmaceutical   unit Hebei Wanbang Folon Pharmaceutical's Tao Hong Si Wu Granules drug registration application was accepted by China's National Medical Products Administration , according to a Tuesday filing with the Hong Kong bourse.The New Drug is a traditional Chinese medicine for nourishing blood, activating blood circulation, and removing blood stasis. It is intended to be used for blood deficiency and blood stasis syndrome, among other issues, the filing added.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600196":"复星医药","BK1230":"工业集团企业","BK0028":"国家队","BK0239":"医药制造","BK0187":"一线龙头","02196":"复星医药","BK0183":"MSCI概念","BK1191":"制药","BK0188":"融资融券","00656":"复星国际","BK0012":"证金概念","BK1593":"医美概念股","BK0175":"白马股","BK0096":"民营医院","BK0196":"行业龙头","BK1515":"抗疫概念","BK0060":"抗癌"},"translate_title":"上海复星医药（集团）血液健康用药获NMPA首肯","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600196":0.9,"00656":1,"02196":0.9},"content_text":"Shanghai Fosun Pharmaceutical (Group) (HKG:2196) unit Hebei Wanbang Folon Pharmaceutical's Tao Hong Si Wu Granules drug registration application was accepted by China's National Medical Products Administration (NMPA), according to a Tuesday filing with the Hong Kong bourse.The New Drug is a traditional Chinese medicine for nourishing blood, activating blood circulation, and removing blood stasis. It is intended to be used for blood deficiency and blood stasis syndrome, among other issues, the filing added.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}